Pharma Journalist -

Asterias Biotherapeutics announced enrollment and dosing of the first subject in the first-in-human Phase 1 clinical trial of AST-VAC2 in the United Kingdom. This initial clinical…
Read More...

Eisai Inc. announced it will launch the Eisai Center for Genetics Guided Dementia Discovery, which will harness the power of human genetics to develop next-generation medicines for…
Read More...

Nordic Nanovector ASA announces that the US Food & Drug Administration (FDA) has granted Fast Track designation to Betalutin (177Lu-lilotomab satetraxetan) for the treatment of…
Read More...

SMi are delighted to have interviewed, speaker, Ioannis Papantoniou, ATMP Bioprocessing Coordinator, Skeletal Biology and Engineering Research Centre, KU Leuven regarding his thoughts…
Read More...

SMi Group are delighted to welcome the expertise from a senior panel of big pharma and ophthalmic organisations, as well as regulatory bodies, at the 2nd annual Ophthalmic Drugs 2018…
Read More...

LabCorp announced that it has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions for biopharmaceutical and…
Read More...

ICON plc announced it has signed an agreement with AG Mednet to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality, for…
Read More...

Alexion Pharmaceuticals and Complement Pharma announced a partnership to co-develop the preclinical C6 complement inhibitor CP010 for neurodegenerative disorders. C6 inhibition prevents…
Read More...

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life, has secured a…
Read More...

Translate Bio announced a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to…
Read More...